|
Before Matching |
Before Matching |
|
After Matching |
After Matching |
|
Baseline/Group |
PR |
SR |
P-value |
PR |
SR |
P-value |
Number of patients |
35,989 |
9,550 |
- |
6,938 |
6,938 |
- |
Mean Age in years (SD) |
64.7(12.6) |
65.1(10.7) |
<0.01 |
65.9 (12.5) |
65.3 (10.7) |
|
Female |
30.8% |
25.7% |
<0.01 |
31.0% |
28.1% |
<0.01 |
ST Elevation AMI |
44.6% |
16.5% |
<0.01 |
21.7% |
21.5% |
0.81 |
Non-ST Elevation AMI |
54.9% |
83.2% |
<0.01 |
77.8% |
78.0% |
0.78 |
Single-vessel Revascularization |
79.9% |
22.2% |
<0.01 |
32.5% |
30.5% |
<0.01 |
Multivessel Revascularization |
20.1% |
41.3% |
<0.01 |
67.5% |
52.4% |
<0.01 |
Hypertension |
78.3% |
87.2% |
<0.01 |
84.5% |
84.9% |
0.48 |
Diabetes Mellitus |
37.5% |
49.7% |
<0.01 |
46.7% |
46.1% |
0.47 |
Hyperlipidemia |
68.9% |
76.8% |
<0.01 |
73.3% |
74.2% |
0.05 |
Chronic Kidney Disease |
16.5% |
20.8% |
<0.01 |
21.5% |
20.6% |
0.16 |
Congestive Heart Failure |
25.0% |
34.4% |
<0.01 |
33.1% |
32.4% |
0.40 |
Systolic Heart Failure |
16.2% |
23.1% |
<0.01 |
21.6% |
21.3% |
0.66 |
Coronary Artery Disease |
86.6% |
93.6% |
<0.01 |
90.7% |
92.0% |
<0.01 |
Chronic Anemia |
12.9% |
21.2% |
<0.01 |
19.7% |
18.6% |
0.09 |
Atrial Fibrillation |
14.0% |
30.6% |
<0.01 |
21.8% |
22.6% |
0.18 |
Atrial Flutter |
1.7% |
4.0% |
<0.01 |
2.9% |
3.0% |
0.80 |
Long-term Anticoagulation |
5.0% |
4.7% |
0.16 |
5.4% |
4.9% |
0.23 |
Aspirin |
21.8% |
26.3% |
<0.01 |
25.2% |
25.4% |
0.78 |
Abnormal Coagulation Profile |
0.3% |
0.6% |
<0.01 |
0.4% |
0.5% |
0.19 |
Peripheral Vascular Disease |
10.7% |
16.0% |
<0.01 |
15.4% |
14.4% |
0.09 |
Chronic Pulmonary Disease |
17.4% |
23.7% |
<0.01 |
22.3% |
22.0% |
0.62 |
Chronic Liver Disease |
1.8% |
3.1% |
<0.01 |
2.5% |
2.6% |
0.78 |
Smoking |
47.0% |
53.0% |
<0.01 |
49.8% |
50.9% |
0.19 |
Obesity |
19.1% |
29.4% |
<0.01 |
25.1% |
25.3% |
0.81 |